Clinical trial

Rapid Build of HIV Related Protective Barriers

NCT03852849

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-03-01

PhaseNA

Study timeline

Study start (estimated)2019-03-01Date precision: day

Registry last updated2019-02-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Viral Suppression of HIV Infectionunresolved

Interventions

Personal involved intervention strategiesBEHAVIORAL

The dosage of 400mg EFVDRUG

Sponsors & collaborators

National Center for AIDS/STD Control and Prevention, China CDClead sponsor

Yunnan Center for Disease Control and Preventioncollaborator

Yunnan AIDS Care Centercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03852849 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.